Clinical Trials
18
Active:0
Completed:15
Trial Phases
3 Phases
Phase 1:8
Phase 2:1
Phase 3:9
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials
Phase 3
9 (50.0%)Phase 1
8 (44.4%)Phase 2
1 (5.6%)Buprenorphine Transdermal Patches Pharmacokinetic Study
- First Posted Date
- 2019-06-05
- Last Posted Date
- 2019-06-05
- Lead Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Target Recruit Count
- 45
- Registration Number
- NCT03975010
- Locations
- 🇨🇳
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China
A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
Phase 3
- Conditions
- Cancer Pain
- Interventions
- First Posted Date
- 2019-05-30
- Last Posted Date
- 2019-06-11
- Lead Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Target Recruit Count
- 194
- Registration Number
- NCT03967327
- Locations
- 🇨🇳
The 81st hospital of the people's liberation army, Nanjing, China
OTR Tablet 10 mg Fasted-state Bioequivalence Study
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT03403504
- Locations
- 🇨🇳
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China
OTR Tablet 40 mg Fasted-state Bioequivalence Study
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Target Recruit Count
- 38
- Registration Number
- NCT03398278
- Locations
- 🇨🇳
West Hospital, Sichuan University, Chengdu, Sichuan, China
OTR Tablet 40 mg Fed-state Bioequivalence Study
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2019-11-15
- Lead Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Target Recruit Count
- 42
- Registration Number
- NCT03398330
- Locations
- 🇨🇳
Xiangya Hospital of Central South University, Changsha, Hunan, China
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found